Close Menu

NEW YORK (360Dx) – 1Drop Diagnostics is developing a portable diagnostic platform that uses a disposable microfluidic biochip to enable inexpensive and rapid testing at the point of care for a broad range of medical conditions.

The platform is undergoing clinical validation and could be ready for regulatory review and clearance within two years, Luc Gervais, the firm's founder and CEO, said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.